Skip to main content

Abstract

“Particle-design engineering” has emerged as a new engineering concept in modern powder technology. Since the early 1980s, micronized active pharmaceutical ingredient (API) powders composed of particles with diameters smaller than 5 μm and exhibiting poor water solubility or dispersible properties have been frequently formulated to improve the bioavailability of original API particles that are larger than around 50 to 100 μm, classified as Class 2 in the biopharmaceutical classification system (BCScriteria [1]. Specifically, fine particles, smaller than 1 μm in diameter, have very large surface energy and specific surface area, resulting in an increased solubility and activity of the original particles. However, it is difficult to disperse such fine particles uniformly in the finished product, due to the segregation caused by their strong cohesive properties. Such fine particle systems should be carefully handled according to the good manufacturing practice (GMP) introduced almost at the same time in the Japanese industry to guarantee the quality of finished products and a reliable manufacturing process. To ensure an optimum process and a suitable formulation for obtaining high-quality pharmaceutical preparations at the industrial scale, the division of Pharmaceutical Preparations and Particulate Design (PPD) [1] was established by the Society of Powder Technology of Japan in cooperation with the Association of Powder Process Industrial Engineering, Japan [2]. As an industry-oriented association, the New Pharmaceutical Technology and Engineering research institute (NPTE Inst.) [3] was first established in Japan in 2005, supported by Powrex Co. Japan. The mission of PPD is to create a new pharmaceutical process and innovative resulting products by paradigm shifting through a particle-design concept, defined as follows: “Particle design is to provide a new function to pharmaceutical preparations or to modify that of pharmaceutical preparations to create innovative medicine or medical device by designing physicochemical properties of particulate material as long as to reserve original chemical properties.” The physicochemical properties of particles are classified as intrinsic primary properties of discrete particles and integrated secondary properties of interacted particles (= powder) and their correlations, as listed in Table 1.1.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Amidon, G.L., Lennernäs, H., Shah, V.P., Crison, J.R.: A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 12(3), 413420. PMID 7617530 (1995, March)

    Google Scholar 

  2. Division of Particulate Design and Preparations, Society of Powder Technology, Japan. http://www.ppd-gifu.com/index.php

  3. The Association of Powder Process Industry and Engineering Japan. http://www.appie.or.jp

  4. New Pharmaceutical Technology and Engineering Research Institute. http://sinseizai.com/

  5. Hersey, J.A.: Ordered mixing: a new concept in powder mixing practice. Powder Technol. 11, 41–44 (1975)

    Article  Google Scholar 

  6. Sundell-Bredenberg, S., Nystrom, C.: The possibility of achieving an interactive mixture with high dose homogeneity containing an extremely low proportion of a micronised drug. Eur. J. Pharm. Sci. 12, 285–295 (2001)

    Article  CAS  Google Scholar 

  7. Tee, S.K., Marriott, C., Zeng, X.M., et al.: The use of different sugars as fine and coarse carriers for aerosolised salbutamol sulphate. Int. J. Pharm. 208, 111–123 (2000)

    Article  CAS  Google Scholar 

  8. Saharana, V.A., Kukkara, V., Katariaa, M., Kharbb, V., Choudhury, P.K.: Ordered mixing: mechanism, process and applications in pharmaceutical formulations. Asian J. Pharm. Sci. 3(6), 240–259 (2008)

    Google Scholar 

  9. Koishi, M., Ishizaka, T., Nakajima, T.: Preparation and surface properties of encapsulated powder pharmaceuticals. Appl. Biochem. Biotechnol. 10, 259–262 (1984)

    Article  CAS  Google Scholar 

  10. Friedrich, H., Nada, A., Bodmeier, R.: Solid state and dissolution rate characterization of co-ground mixtures of nifedipine and hydrophilic carriers. Drug Dev. Ind. Pharm. 31(8), 719–728 (2005, Sep)

    Article  CAS  Google Scholar 

  11. Nakai, Y.: Molecular behavior of medicinals in ground mixtures with microcrystalline cellulose and cyclodextrins. Drug Dev. Ind. Pharm. 12, 1017–1039 (1986)

    Article  CAS  Google Scholar 

  12. Lonare, A., Patel, S.R.: Int. Chem. Eng. Appl. 4(5), 337–341 (2013)

    CAS  Google Scholar 

  13. Stock, D.I.: Micro-spherical aggregation of barium sulphate. Nature. 170, 423 (1952)

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kawashima, Y. (2019). Introduction. In: Spherical Crystallization as a New Platform for Particle Design Engineering. Springer, Singapore. https://doi.org/10.1007/978-981-13-6786-1_1

Download citation

Publish with us

Policies and ethics